TAYLOR BURGART: Open Payments
NPI 1801666938 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,019 in 43 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $505 · 2025 $1,019
Food & beverage: $919Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $188 |
| Daiichi Sankyo Inc. | 7 | $152 |
| Janssen Biotech, Inc. | 4 | $88 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| Astellas Pharma US Inc | 2 | $47 |
| Rigel Pharmaceuticals, Inc. | 2 | $42 |
| Immunocore Limited | 1 | $34 |
| Gilead Sciences, Inc. | 1 | $33 |
| Karyopharm Therapeutics Inc. | 1 | $28 |
Products named: Enhertu, KISQALI, KEYTRUDA, Padcev, TAVALISSE, KIMMTRAK, Trodelvy, XPOVIO.
Industry payments across CO — which companies pay providers there.
